Lys335

Site Information
HPsPAKLkATAGH__ SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 41682221
Available spectra: 1 CST

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 , 4 , 5 , 6 )
Disease tissue studied:	lung cancer ( 1 , 2 , 3 , 4 , 5 ) , non-small cell lung cancer ( 2 , 3 , 4 , 5 , 6 ) , non-small cell lung adenocarcinoma ( 2 , 4 , 5 , 6 ) , non-small cell large cell lung carcinoma ( 2 , 4 ) , small-cell lung cancer ( 1 )
Relevant cell line - cell type - tissue:	Cal-12T (pulmonary) ( 5 ) , Calu-3 (pulmonary) ( 3 ) , DMS53 (pulmonary) ( 1 ) , HCC44 (pulmonary) ( 5 ) , HCC78 (pulmonary) ( 4 ) , HCC827 (pulmonary) ( 3 ) , lung ( 1 , 2 , 3 , 4 , 5 ) , NCI-H1299 (pulmonary) ( 2 ) , NCI-H1437 (pulmonary) ( 5 ) , NCI-H1650 (pulmonary) ( 3 ) , NCI-H1666 (pulmonary) ( 5 ) , NCI-H1734 (pulmonary) ( 2 ) , NCI-H1781 (pulmonary) ( 4 ) , NCI-H1944 (pulmonary) ( 2 ) , NCI-H1975 (pulmonary) ( 3 ) , NCI-H2106 (pulmonary) ( 3 ) , NCI-H2228 (pulmonary) ( 4 , 6 ) , NCI-H2405 (pulmonary) ( 5 ) , NCI-H3122 (pulmonary) ( 4 ) , NCI-H358 (pulmonary) ( 2 ) , NCI-H446 (pulmonary) ( 1 ) , NCI-H460 (pulmonary) ( 2 ) , NCI-H526 (pulmonary) ( 1 ) , NCI-H661 (pulmonary) ( 4 ) , NCI-H69 (pulmonary) ( 1 ) , NCI-H82 (pulmonary) ( 1 )

References
1	Rikova K (2013) CST Curation Set: 20126; Year: 2013; Biosample/Treatment: cell line, DMS53, H526, H69, H82, H446; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
2	Rikova K (2013) CST Curation Set: 20128; Year: 2013; Biosample/Treatment: cell line, H1299, H1944, H358, H1734, H460; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
3	Rikova K (2013) CST Curation Set: 20129; Year: 2013; Biosample/Treatment: cell line, H1650, HCC827, H1975, Calu-3, H2106; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
4	Rikova K (2013) CST Curation Set: 20131; Year: 2013; Biosample/Treatment: cell line, H2228, H3122, HCC78, H661, H1781; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
5	Rikova K (2013) CST Curation Set: 20132; Year: 2013; Biosample/Treatment: cell line, H1666, CAL-12T, H2405, HCC44, H1437; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info
6	Rikova K (2013) CST Curation Set: 18852; Year: 2013; Biosample/Treatment: cell line, H2228/crizotinib, geldanamycin; Disease: -; TMT: Y; Specificities of Antibodies Used to Purify Peptides prior to LCMS: m1K Curated Info